These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26494028)

  • 1. Soluble epoxide hydrolase inhibitor enhances synaptic neurotransmission and plasticity in mouse prefrontal cortex.
    Wu HF; Yen HJ; Huang CC; Lee YC; Wu SZ; Lee TS; Lin HC
    J Biomed Sci; 2015 Oct; 22():94. PubMed ID: 26494028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis.
    Kuo YM; Hsu PC; Hung CC; Hu YY; Huang YJ; Gan YL; Lin CH; Shie FS; Chang WK; Kao LS; Tsou MY; Lee YH
    Mol Neurobiol; 2019 Dec; 56(12):8451-8474. PubMed ID: 31257558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Epoxide Hydrolase Inhibitor and 14,15-Epoxyeicosatrienoic Acid-Facilitated Long-Term Potentiation through cAMP and CaMKII in the Hippocampus.
    Wu HF; Chen YJ; Wu SZ; Lee CW; Chen IT; Lee YC; Huang CC; Hsing CH; Tang CW; Lin HC
    Neural Plast; 2017; 2017():3467805. PubMed ID: 29138698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
    Zhang W; Koerner IP; Noppens R; Grafe M; Tsai HJ; Morisseau C; Luria A; Hammock BD; Falck JR; Alkayed NJ
    J Cereb Blood Flow Metab; 2007 Dec; 27(12):1931-40. PubMed ID: 17440491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of soluble epoxide hydrolase attenuates post-ischemic neuronal hyperexcitation and confers resilience against stroke with TrkB activation.
    Chang LH; Lin HC; Huang SS; Chen IC; Chu KW; Chih CL; Liang YW; Lee YC; Chen YY; Lee YH; Lee IH
    Sci Rep; 2018 Jan; 8(1):118. PubMed ID: 29311641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
    Olearczyk JJ; Field MB; Kim IH; Morisseau C; Hammock BD; Imig JD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1307-14. PubMed ID: 16772540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway.
    Liang Y; Jing Z; Deng H; Li Z; Zhuang Z; Wang S; Wang Y
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):70-5. PubMed ID: 25986738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.
    Dorrance AM; Rupp N; Pollock DM; Newman JW; Hammock BD; Imig JD
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):842-8. PubMed ID: 16306811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.
    Jung O; Brandes RP; Kim IH; Schweda F; Schmidt R; Hammock BD; Busse R; Fleming I
    Hypertension; 2005 Apr; 45(4):759-65. PubMed ID: 15699457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of soluble epoxide hydrolase attenuates airway remodeling in a chronic asthma model.
    Jiang JX; Guan Y; Shen HJ; Jia YL; Shen J; Zhang LH; Liu Q; Zhu YL; Xie QM
    Eur J Pharmacol; 2020 Feb; 868():172874. PubMed ID: 31866410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
    Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
    J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of α₁-adrenoceptors enhances excitatory synaptic transmission via a pre- and postsynaptic protein kinase C-dependent mechanism in the medial prefrontal cortex of rats.
    Luo F; Tang H; Li BM; Li SH
    Eur J Neurosci; 2014 Apr; 39(8):1281-93. PubMed ID: 24494713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase activity determines the severity of ischemia-reperfusion injury in kidney.
    Lee JP; Yang SH; Lee HY; Kim B; Cho JY; Paik JH; Oh YJ; Kim DK; Lim CS; Kim YS
    PLoS One; 2012; 7(5):e37075. PubMed ID: 22590647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of the soluble epoxide hydrolase (sEH) inhibitor AUDA on atherosclerotic diseases.
    Zhang J; Liu YS; Lu QH
    Pharmazie; 2015 Jan; 70(1):24-8. PubMed ID: 25975094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase.
    Kim IH; Nishi K; Tsai HJ; Bradford T; Koda Y; Watanabe T; Morisseau C; Blanchfield J; Toth I; Hammock BD
    Bioorg Med Chem; 2007 Jan; 15(1):312-23. PubMed ID: 17046265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection.
    Simpkins AN; Rudic RD; Schreihofer DA; Roy S; Manhiani M; Tsai HJ; Hammock BD; Imig JD
    Am J Pathol; 2009 Jun; 174(6):2086-95. PubMed ID: 19435785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linoleic Acid Metabolite DiHOME Decreases Post-ischemic Cardiac Recovery in Murine Hearts.
    Bannehr M; Löhr L; Gelep J; Haverkamp W; Schunck WH; Gollasch M; Wutzler A
    Cardiovasc Toxicol; 2019 Aug; 19(4):365-371. PubMed ID: 30725262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
    Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.
    Imig JD; Zhao X; Zaharis CZ; Olearczyk JJ; Pollock DM; Newman JW; Kim IH; Watanabe T; Hammock BD
    Hypertension; 2005 Oct; 46(4):975-81. PubMed ID: 16157792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.